Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current protocols and outcomes for colonic cancer: why do we fail?

K J Guleserian1, K I Bland

  • 1Department of Surgery, Brown University School of Medicine, Rhode Island Hospital, Providence, Rhode Island, USA.

Surgical Oncology Clinics of North America
|September 29, 2000
PubMed
Summary

Colorectal cancer is a major health concern. Advances in treatment and ongoing research into prevention, immunotherapy, and gene therapy promise more effective strategies for patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cellular mechanisms of injury after major trauma.

The British journal of surgery·2009
Same author

Radio-frequency ablation in cirrhotic patients with hepatocellular carcinoma.

The American surgeon·2004
Same author

Biomarkers for breast cancer.

Minerva chirurgica·2002
Same author

Cyclooxygenase-2-mediated regulation of Kupffer cell interleukin-6 production following trauma-hemorrhage and subsequent sepsis.

Shock (Augusta, Ga.)·2002
Same author

Testosterone and estrogen differently effect Th1 and Th2 cytokine release following trauma-haemorrhage.

Cytokine·2001
Same author

Attenuation of vascular endothelial dysfunction by testosterone receptor blockade after trauma and hemorrhagic shock.

Archives of surgery (Chicago, Ill. : 1960)·2001

Area of Science:

  • Oncology
  • Gastroenterology
  • Public Health

Background:

  • Colorectal cancer is the second leading cause of cancer-related deaths in the United States.
  • Significant progress in diagnosis, screening, surgery, and adjuvant therapy has improved survival rates over the last three decades.

Purpose of the Study:

  • To review the current state and future directions in colorectal cancer management.
  • To highlight the potential of novel therapies and research areas.

Main Methods:

  • Review of recent advances in colorectal cancer diagnosis and treatment.
  • Discussion of emerging therapeutic strategies including immunotherapy and gene therapy.
  • Emphasis on the importance of disease prevention and understanding tumor biology.

Related Experiment Videos

Main Results:

  • Survival rates for colorectal cancer have improved due to advancements in care.
  • Novel therapies are in early development but show significant promise for future treatment.
  • Continued research in prevention, tumor biology, immunotherapy, and gene therapy is crucial.

Conclusions:

  • Future colorectal cancer management will benefit from continued research and interdisciplinary collaboration.
  • Enhanced understanding of tumor biology and novel therapeutic approaches like immunotherapy and gene therapy are expected to yield more effective treatments.
  • A focus on prevention and early detection remains vital for reducing mortality.